Marina Lyubimova
⬤ Hims & Hers Health (NASDAQ: HIMS) is trading at a make-or-break support zone around $33. If the stock can't hold this level, analysts are eyeing $25 as the next likely landing spot. The chart shows HIMS sliding lower in recent weeks, approaching previous support levels while trading below its longer-term moving averages—not a great technical picture.
⬤ Sentiment toward HIMS has hit rock bottom, reportedly the weakest it's ever been. Recent management communication hasn't helped, adding fuel to the negative perception. Here's the twist though: the company's fundamentals are still solid. The issue? Growth is slowing down. Traders are treating $33 as the line in the sand—hold it, and there's hope; break it, and we're looking at a slide into the mid-$20s.
⬤ The chart tells the story of an extended correction after HIMS traded at much higher levels earlier in the cycle. Right now, the market is sitting on the fence, reacting to both company news and broader sentiment pressures as the stock consolidates near support.
Marina Lyubimova
